Cellipont Receives Strategic Debt Investment from OrbiMed
New facility in The Woodlands, TX accelerates Cellipont’s cell therapy innovation Cellipont Bioservices (Cellipont), a cell therapy contract development and manufacturing organization (CDMO), announced a strategic debt facility investment from OrbiMed, a healthcare investment firm. The investment will be used by Cellipont to fully finance the previously announced state-of-the-art commercial facility for......